A correlation study of CSF neuropeptides in Alzheimer's and Parkinson's disease

J. Jolkkonen, P. Hartikainen, R. Soikkeli, G. Bissette, Charles Nemeroff, P. Riekkinen

Research output: Contribution to journalArticle

18 Citations (Scopus)

Abstract

The concentrations of somatostatin (SRIF), vasoactive intestinal polypeptide (VIP), β-endorphin (β-EP), adrenocorticotropin (ACTH) and corticotropin-releasing factor (CRF) immunoreactivity were measured in cerebrospinal fluid (CSF) of patients with Alzheimer's disease (AD), patients with Parkinson's disease (PD) and controls. In order to study the mechanisms that regulate peptide levels in CSF and peptide interactions, correlations between CSF peptides were determined. Within all patient groups a number of significant correlations were shown to exist between CSF peptides. The correlations were apparently not coincidental, since there was no such relation between the concentrations of CSF peptides and CSF protein content. Neither age, sex, severity of dementia nor the presence of extrapyramidal signs could explain the number of significant correlations. These results indicate, that the correlations found between CSF peptides may be due to common regulatory mechanisms or general physiological behaviour of peptides in the CSF.

Original languageEnglish
Pages (from-to)97-102
Number of pages6
JournalNeuropeptides
Volume19
Issue number2
DOIs
StatePublished - Jan 1 1991
Externally publishedYes

Fingerprint

Cerebrospinal fluid
Neuropeptides
Parkinson Disease
Cerebrospinal Fluid
Alzheimer Disease
Peptides
Corticotropin-Releasing Hormone
Endorphins
Cerebrospinal Fluid Proteins
Vasoactive Intestinal Peptide
Somatostatin
Adrenocorticotropic Hormone
Dementia

ASJC Scopus subject areas

  • Biochemistry
  • Endocrinology
  • Endocrinology, Diabetes and Metabolism
  • Clinical Neurology
  • Neuroscience(all)
  • Cellular and Molecular Neuroscience

Cite this

Jolkkonen, J., Hartikainen, P., Soikkeli, R., Bissette, G., Nemeroff, C., & Riekkinen, P. (1991). A correlation study of CSF neuropeptides in Alzheimer's and Parkinson's disease. Neuropeptides, 19(2), 97-102. https://doi.org/10.1016/0143-4179(91)90138-9

A correlation study of CSF neuropeptides in Alzheimer's and Parkinson's disease. / Jolkkonen, J.; Hartikainen, P.; Soikkeli, R.; Bissette, G.; Nemeroff, Charles; Riekkinen, P.

In: Neuropeptides, Vol. 19, No. 2, 01.01.1991, p. 97-102.

Research output: Contribution to journalArticle

Jolkkonen, J, Hartikainen, P, Soikkeli, R, Bissette, G, Nemeroff, C & Riekkinen, P 1991, 'A correlation study of CSF neuropeptides in Alzheimer's and Parkinson's disease', Neuropeptides, vol. 19, no. 2, pp. 97-102. https://doi.org/10.1016/0143-4179(91)90138-9
Jolkkonen, J. ; Hartikainen, P. ; Soikkeli, R. ; Bissette, G. ; Nemeroff, Charles ; Riekkinen, P. / A correlation study of CSF neuropeptides in Alzheimer's and Parkinson's disease. In: Neuropeptides. 1991 ; Vol. 19, No. 2. pp. 97-102.
@article{f27b8df6e60b4a46b0ef81ac3de1d142,
title = "A correlation study of CSF neuropeptides in Alzheimer's and Parkinson's disease",
abstract = "The concentrations of somatostatin (SRIF), vasoactive intestinal polypeptide (VIP), β-endorphin (β-EP), adrenocorticotropin (ACTH) and corticotropin-releasing factor (CRF) immunoreactivity were measured in cerebrospinal fluid (CSF) of patients with Alzheimer's disease (AD), patients with Parkinson's disease (PD) and controls. In order to study the mechanisms that regulate peptide levels in CSF and peptide interactions, correlations between CSF peptides were determined. Within all patient groups a number of significant correlations were shown to exist between CSF peptides. The correlations were apparently not coincidental, since there was no such relation between the concentrations of CSF peptides and CSF protein content. Neither age, sex, severity of dementia nor the presence of extrapyramidal signs could explain the number of significant correlations. These results indicate, that the correlations found between CSF peptides may be due to common regulatory mechanisms or general physiological behaviour of peptides in the CSF.",
author = "J. Jolkkonen and P. Hartikainen and R. Soikkeli and G. Bissette and Charles Nemeroff and P. Riekkinen",
year = "1991",
month = "1",
day = "1",
doi = "10.1016/0143-4179(91)90138-9",
language = "English",
volume = "19",
pages = "97--102",
journal = "Neuropeptides",
issn = "0143-4179",
publisher = "Churchill Livingstone",
number = "2",

}

TY - JOUR

T1 - A correlation study of CSF neuropeptides in Alzheimer's and Parkinson's disease

AU - Jolkkonen, J.

AU - Hartikainen, P.

AU - Soikkeli, R.

AU - Bissette, G.

AU - Nemeroff, Charles

AU - Riekkinen, P.

PY - 1991/1/1

Y1 - 1991/1/1

N2 - The concentrations of somatostatin (SRIF), vasoactive intestinal polypeptide (VIP), β-endorphin (β-EP), adrenocorticotropin (ACTH) and corticotropin-releasing factor (CRF) immunoreactivity were measured in cerebrospinal fluid (CSF) of patients with Alzheimer's disease (AD), patients with Parkinson's disease (PD) and controls. In order to study the mechanisms that regulate peptide levels in CSF and peptide interactions, correlations between CSF peptides were determined. Within all patient groups a number of significant correlations were shown to exist between CSF peptides. The correlations were apparently not coincidental, since there was no such relation between the concentrations of CSF peptides and CSF protein content. Neither age, sex, severity of dementia nor the presence of extrapyramidal signs could explain the number of significant correlations. These results indicate, that the correlations found between CSF peptides may be due to common regulatory mechanisms or general physiological behaviour of peptides in the CSF.

AB - The concentrations of somatostatin (SRIF), vasoactive intestinal polypeptide (VIP), β-endorphin (β-EP), adrenocorticotropin (ACTH) and corticotropin-releasing factor (CRF) immunoreactivity were measured in cerebrospinal fluid (CSF) of patients with Alzheimer's disease (AD), patients with Parkinson's disease (PD) and controls. In order to study the mechanisms that regulate peptide levels in CSF and peptide interactions, correlations between CSF peptides were determined. Within all patient groups a number of significant correlations were shown to exist between CSF peptides. The correlations were apparently not coincidental, since there was no such relation between the concentrations of CSF peptides and CSF protein content. Neither age, sex, severity of dementia nor the presence of extrapyramidal signs could explain the number of significant correlations. These results indicate, that the correlations found between CSF peptides may be due to common regulatory mechanisms or general physiological behaviour of peptides in the CSF.

UR - http://www.scopus.com/inward/record.url?scp=0025801419&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0025801419&partnerID=8YFLogxK

U2 - 10.1016/0143-4179(91)90138-9

DO - 10.1016/0143-4179(91)90138-9

M3 - Article

VL - 19

SP - 97

EP - 102

JO - Neuropeptides

JF - Neuropeptides

SN - 0143-4179

IS - 2

ER -